Andrew Huberman: Yeah, I feel that resembles the dopamine pathway
Marx N, Federici M, Schutt K, Muller-Wieland D, Ajjan RA, Antunes MJ, et al
OSA is extremely common in people with obesity, and a treatment that simultaneously reduces weight and improves sleep apnea could earn a specific labeled indication
If all goes to plan and you can tolerate the treatment, your dosing schedule will look like this: What happens if you miss a dose of Mounjaro
RT10 10mg Pharmacokinetics and Triple-Agonist Signaling A defining characteristic of this research fragment is its highly optimized pharmacokinetic profile
In contrast, among patients whose baseline regimen included dapagliflozin, GLP-1 RA therapy was not associated with significant within-group worsening of HRV indices, and HRV measures remained relatively stable over time